• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一本关于人类乳腺大体病理的图谱,特别提及可能的癌前病变。

An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions.

作者信息

Wellings S R, Jensen H M, Marcum R G

出版信息

J Natl Cancer Inst. 1975 Aug;55(2):231-73.

PMID:169369
Abstract

One hundred ninety-six whole human breasts were examined by a subgross sampling technique with histologic confirmation. The method permitted the enumeration and identification of essentially all the focal dysplastic, metaplastic, hyperplastic, anaplastic, and neoplastic lesions. Of the 196, 119 were suitable for complete quantitative morphologic analysis of the focal lesions by type. They consisted of 67 breasts obtained by autopsy, 29 cancerous breasts obtained by mastectomy, and 23 contralateral to those with cancer. All lesions, photographed subgrossly, were subsequently confirmed and correlated histologically. Morphologic evidence supported the hypothesis that most lesions traditionally grouped as mammary dysplasia or fibrocystic disease, including apocrine cysts, sclerosing adenosis, fibroadenomas, various forms of lobules (sclerotic, dilated, hypersecretory, hyperplastic, atypical, or anaplastic), ductal carcinoma in situ (DCIS), and lobular carcinoma in situ (LCIS), arose in terminal ductal-lobular units (TDLU) or in the lobules themselves. A probable exception was papilloma of ducts larger than terminal ones. Isolated foci of DCIS within the TDLU were seen in 40% of cancerous breasts, which indicated that the disease often was multifocal. Of the contralateral breasts, the 60% with clinical cancer contained such lesions, and data were in accord with the clinically known fact that women with previous breast cancer have a high rate of the disease in the remaining one. An atypical lobule (AL) of type A (ALA) had the following characteristics: a) It was more common in cancerous breasts or in those contralateral to cancer than in breasts not so identified; b) it had lobular morphology and was a terminal structure on the mammary tree; c) it tended to persist after the menopause, whereas normal lobules usually atrophied; d) it variable degrees of anaplasia forming an arbitrary continuum from normal lobules to ductal carcinoma in situ; and e) as ALA progressed to DCIS, the unfolded lobule resembled a duct which gave the false impression that DCIS was a ductal lesion. The morphologic evidence supported that hypothesis that the lesions herein called AL were derived from TDLU and were precancerous.

摘要

采用亚大体取样技术并经组织学证实,对196个完整的人类乳房进行了检查。该方法能够对基本上所有局灶性发育异常、化生、增生、间变和肿瘤性病变进行计数和识别。在这196个乳房中,119个适合按类型对局灶性病变进行完整的定量形态学分析。它们包括通过尸检获得的67个乳房、通过乳房切除术获得的29个癌性乳房以及与癌性乳房相对的23个对侧乳房。所有病变均在亚大体水平拍照,随后进行组织学证实和关联分析。形态学证据支持这样一种假说,即大多数传统上归类为乳腺发育异常或纤维囊性疾病的病变,包括大汗腺囊肿、硬化性腺病、纤维腺瘤、各种形式的小叶(硬化性、扩张性、分泌过多性、增生性、非典型性或间变性)、导管原位癌(DCIS)和小叶原位癌(LCIS),均起源于终末导管小叶单位(TDLU)或小叶本身。一个可能的例外是大于终末导管的导管内乳头状瘤。在40%的癌性乳房中可见TDLU内孤立的DCIS病灶,这表明该疾病常为多灶性。在对侧乳房中,60%有临床癌症的乳房含有此类病变,数据与临床已知事实相符,即既往有乳腺癌的女性另一侧乳房患该疾病的几率很高。A型非典型小叶(ALA)具有以下特征:a)它在癌性乳房或与癌相对的乳房中比在未发现此类情况的乳房中更常见;b)它具有小叶形态,是乳腺树上的终末结构;c)它在绝经后往往持续存在,而正常小叶通常会萎缩;d)它有不同程度的间变,形成从正常小叶到导管原位癌的任意连续谱;e)当ALA进展为DCIS时,展开的小叶类似导管,给人一种DCIS是导管病变的错误印象。形态学证据支持这样的假说,即此处称为AL的病变起源于TDLU且是癌前病变。

相似文献

1
An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions.一本关于人类乳腺大体病理的图谱,特别提及可能的癌前病变。
J Natl Cancer Inst. 1975 Aug;55(2):231-73.
2
The microenvironment of human breast with clinical cancer.
Appl Pathol. 1983 Nov-Dec;1(6):323-32.
3
Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy.同时存在的增殖性高危病变对接受保乳治疗的导管原位癌患者同侧乳腺癌复发风险及对侧乳腺癌发生风险的影响。
Cancer. 2006 Jan 1;106(1):42-50. doi: 10.1002/cncr.21571.
4
Bilateral and multifocal breast carcinoma. A clinical and autopsy study with special emphasis on carcinoma in situ.双侧及多灶性乳腺癌。一项特别关注原位癌的临床与尸检研究。
Eur J Surg Oncol. 1991 Feb;17(1):20-9.
5
Clinicopathologic analysis of breast lesions associated with multiple papillomas.与多发性乳头状瘤相关的乳腺病变的临床病理分析
Hum Pathol. 2003 Mar;34(3):234-9. doi: 10.1053/hupa.2003.25.
6
Structure, functional changes, and proliferative pathology of the human mammary lobule in cancerous breasts.
J Natl Cancer Inst. 1981 Jul;67(1):33-46.
7
Angiogenesis and VEGF expression in pre-invasive lesions of the human breast.人乳腺浸润前病变中的血管生成与血管内皮生长因子表达
J Pathol. 2004 Oct;204(2):140-6. doi: 10.1002/path.1626.
8
The prevalence of carcinoma in situ in normal and cancer-associated breasts.正常乳腺及癌相关乳腺中导管原位癌的患病率。
Hum Pathol. 1985 Aug;16(8):796-807. doi: 10.1016/s0046-8177(85)80251-3.
9
Stereotaxic fine needle aspiration cytology of clinically occult malignant and premalignant breast lesions.临床隐匿性乳腺恶性和癌前病变的立体定向细针穿刺细胞学检查
Acta Cytol. 1988 Mar-Apr;32(2):193-201.
10
Preneoplastic lesions of the human mammary gland transplanted into the nude athymic mouse.移植到无胸腺裸鼠体内的人类乳腺的癌前病变。
Cancer Res. 1976 Jul;36(7 PT 2):2605-10.

引用本文的文献

1
Efficacy of Melatonin in Alleviating Radiotherapy-Induced Fatigue, Anxiety, and Depression in Breast Cancer Patients: A Randomized, Triple-Blind, Placebo-Controlled Trial.褪黑素缓解乳腺癌患者放疗所致疲劳、焦虑和抑郁的疗效:一项随机、三盲、安慰剂对照试验
Integr Cancer Ther. 2025 Jan-Dec;24:15347354251371705. doi: 10.1177/15347354251371705. Epub 2025 Sep 1.
2
CD105 fibroblasts support an immunosuppressive niche in women at high risk of breast cancer initiation.CD105 成纤维细胞在乳腺癌发病高危女性中支持免疫抑制微环境。
Breast Cancer Res. 2025 May 15;27(1):81. doi: 10.1186/s13058-025-02040-7.
3
Aromatics from fossil fuels and breast cancer.
来自化石燃料的芳烃与乳腺癌
iScience. 2025 Mar 10;28(4):112204. doi: 10.1016/j.isci.2025.112204. eCollection 2025 Apr 18.
4
Methanolic Leaves Extract of Inhibits Cell Proliferation and Migration of HER2-Positive Breast Cancer via p38 MAPK Signaling Pathway.[植物名称]的甲醇叶提取物通过p38丝裂原活化蛋白激酶信号通路抑制HER2阳性乳腺癌细胞的增殖和迁移 。 (注:原文中“Inhibits Cell Proliferation and Migration of HER2-Positive Breast Cancer via p38 MAPK Signaling Pathway.”前面缺少具体植物名称,这里翻译时补充了“[植物名称]”,以便使句子完整通顺)
Int J Mol Sci. 2025 Jan 14;26(2):654. doi: 10.3390/ijms26020654.
5
Cells-of-Origin of Breast Cancer and Intertumoral Heterogeneity.乳腺癌的起源细胞与肿瘤间异质性
Adv Exp Med Biol. 2025;1464:151-165. doi: 10.1007/978-3-031-70875-6_9.
6
Genome-wide characterization of dynamic DNA 5-hydroxymethylcytosine and TET2-related DNA demethylation during breast tumorigenesis.在乳腺癌发生过程中,全基因组范围内对动态 DNA 5-羟甲基胞嘧啶和 TET2 相关 DNA 去甲基化的研究。
Clin Epigenetics. 2024 Sep 11;16(1):125. doi: 10.1186/s13148-024-01726-7.
7
Analysis of ductal carcinoma in situ by self-reported race reveals molecular differences related to outcome.基于自我报告的种族分析导管原位癌揭示了与预后相关的分子差异。
Breast Cancer Res. 2024 Sep 2;26(1):127. doi: 10.1186/s13058-024-01885-8.
8
Heterogeneous Evolution of Breast Cancer Cells-An Endogenous Molecular-Cellular Network Study.乳腺癌细胞的异质性进化——一项内源性分子-细胞网络研究
Biology (Basel). 2024 Jul 26;13(8):564. doi: 10.3390/biology13080564.
9
Progression from ductal carcinoma in situ to invasive breast cancer: molecular features and clinical significance.从导管原位癌到浸润性乳腺癌的进展:分子特征及临床意义。
Signal Transduct Target Ther. 2024 Apr 3;9(1):83. doi: 10.1038/s41392-024-01779-3.
10
Thermosensitive Polymeric Nanoparticles for Drug Co-Encapsulation and Breast Cancer Treatment.用于药物共包封和乳腺癌治疗的热敏聚合物纳米颗粒。
Pharmaceutics. 2024 Feb 5;16(2):231. doi: 10.3390/pharmaceutics16020231.